Ad
related to: phase i clinical trials
Search results
EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial
Clinical Trials Arena via Yahoo Finance· 56 minutes agoAt the 2024 Congress of the European Hematology Association (EHA 2024) on 14 June, preliminary...
Takeda’s epilepsy drug misses the mark in two Phase III trials
Clinical Trials Arena via Yahoo Finance· 1 hour agoThe SKYLINE trial was a double-blind Phase III study evaluating soticlestat plus standard of care...
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena via Yahoo Finance· 7 hours agoAstraZeneca has reported positive data from the ECHO Phase III clinical trial where its Calquence...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoPfizer has announced findings from the Phase II MagnetisMM-3 clinical trial of ELREXFIO...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 1 hour agoThe data from the Phase I/II LINKER-MM1 (NCT03761108) study was...response or better, as determined...
Roche’s Columvi offers extended survival in Phase III DLBCL trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoRoche has reported findings from the Phase III STARGLO clinical trial where Columvi, in combination...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 4 hours agoGlobalData is the parent company of the Clinical Trials Arena. MM is a form of blood cancer that...
Baird lifts Mirum Pharmaceuticals shares target on study results By Investing.com
Investing.com· 3 hours ago(NASDAQ:MIRM) shares to $39 from the previous $34, while maintaining an Outperform rating on the...
Beacon Therapeutics treats first patient with AGTC-501 in pivotal VISTA trial
Clinical Trials Arena via Yahoo Finance· 1 hour agoResults from AGTC-501’s ongoing Phase II SKYLINE trial (NCT03316560) revealed that at 12 months, 63%...
Johnson & Johnson’s nipocalimab shows promise in Sjögren’s disease trial
Clinical Trials Arena via Yahoo Finance· 7 hours agoThis study included a Phase II dose-ranging trial for adults with moderately-to-severely active...
